Weifa AS has signed a definitive agreement to acquire Cederroth A/S from Orkla ASA.
Weifa AS, a listed Norway-based pharmaceutical company headquartered in Oslo, is engaged in the research, development, production, distribution, and sales of medicines, lifestyle products, and solutions.
Cederroth International AB, a Sweden-based company headquartered in Upplands Vasby, is a provider of products covering health care, personal care, first aid and household sectors and a subsidiary of Orkla ASA.
Orkla ASA, a listed Norway-based company headquartered in Oslo, operates in branded consumer goods, aluminum solutions, renewable energy, materials, and financial investment sectors through its subsidiaries.
Cederroth’s Asan portfolio complements Weifa’s current offering of intimate care products and strengthens the latter’s position as a leading consumer health company. The acquisition will enable Weifa to utilize its core competencies to develop the Asan portfolio further. The transaction is in line with Weifa’s strategy of expanding organically and by acquisitions, in addition to its ambition of establishing a Nordic market position. The transaction will be accretive on Weifa’s net profit from the first year of operation.
Sources:
Weifa AS press release, 17 December 2015
Orkla ASA press release,17 December 2015
Alpha Corporate Finance press release, 17 December 2015
Orkla ASA press release,15 January 2016
Alpha Corporate Finance
Advised in the sale of
Cederroth A/S
to